Figure 3From: Poxvirus-based vaccine therapy for patients with advanced pancreatic cancerOverall survival of patients enrolled in the study. Positive indicates patients who had evidence of the development of a carcinoembryonic antigen (CEA)- and/or mucin-1 (MUC-1)-specific immune response. Negative indicates patients who did not develop an immune response (n = 3) or who were not assayed (n = 2).Back to article page